Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FMISO”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Early research (Phase 1)Ended earlyNCT03730077
What this trial is testing

FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas

Who this might be right for
Soft Tissue Sarcoma
University of Pennsylvania 5
Not applicableLooking for participantsNCT05348486
What this trial is testing

FMISO-based Adaptive Radiotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerHypoxiaFMISO+1 more
University Hospital Olomouc 120
Large-scale testing (Phase 3)Looking for participantsNCT06563479
What this trial is testing

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

Who this might be right for
HPV-Related Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 291
Testing effectiveness (Phase 2)Ended earlyNCT01619696
What this trial is testing

Prospective Pilot Study of Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy of Rectal Adenocarcinomas

Who this might be right for
Rectal Adenocarcinoma
University Hospital, Toulouse 3
Not applicableEnded earlyNCT01613521
What this trial is testing

Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer

Who this might be right for
Cervical Cancer
Memorial Sloan Kettering Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT05544136
What this trial is testing

Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck CarcinomaHead and Neck Neoplasms+1 more
Memorial Sloan Kettering Cancer Center 12
Not applicableStudy completedNCT02016872
What this trial is testing

Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients

Who this might be right for
Non-Small-Cell-Lung Cancer (NSCLC)
Memorial Sloan Kettering Cancer Center 25
Not applicableUnknownNCT06433063
What this trial is testing

Effect of Hypoxia on FMISO PET to Response to Lu-177 PSMA Treatment

Who this might be right for
Prostatic NeoplasmsHypoxia
Cigdem Soydal 30
Testing effectiveness (Phase 2)Study completedNCT02695628
What this trial is testing

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Who this might be right for
Adult Liver CarcinomaLiver Cirrhosis
Stanford University 5
Not applicableUnknownNCT03716986
What this trial is testing

Multimodal Imaging of Hypoxia in Gliomas

Who this might be right for
Glioma
University Hospital, Caen 20
Not applicableStudy completedNCT01261585
What this trial is testing

Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT

Who this might be right for
Bronchial NeoplasmsCarcinoma, Non-Small-Cell Lung
Centre Henri Becquerel 5
Testing effectiveness (Phase 2)Ended earlyNCT03303469
What this trial is testing

Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging

Who this might be right for
Hepatocellular Carcinoma
University of Alabama at Birmingham 3
Testing effectiveness (Phase 2)Looking for participantsNCT03649880
What this trial is testing

Feasibility of FMISO in Brain Tumors

Who this might be right for
IDH Wild Type Glioblastoma
OHSU Knight Cancer Institute 77
Testing effectiveness (Phase 2)Ended earlyNCT01169350
What this trial is testing

18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma

Who this might be right for
Recurrent Adult Soft Tissue SarcomaStage I Adult Soft Tissue SarcomaStage II Adult Soft Tissue Sarcoma+2 more
National Cancer Institute (NCI) 8
Not applicableStudy completedNCT02076152
What this trial is testing

FMISO PET Study of Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Massachusetts General Hospital 11
Early research (Phase 1)Study completedNCT03547388
What this trial is testing

Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor Microenvironment

Who this might be right for
Head and Neck NeoplasmsRecurrence Tumor
Charite University, Berlin, Germany 10
Early research (Phase 1)Study completedNCT05331729
What this trial is testing

Evaluation of the Value of 18F-Fluoromisonidazole (18F-FMISO) Positron Emission Tomography Hypoxia Imaging in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Centre Hospitalier Universitaire Dijon 20